Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Understanding Meningococcal Disease

Asian Pac J Trop Med; 2017 Nov; Batista, et al

Neisseria meningitidis, the microbe that causes meningococcal disease, is a uniquely human pathogen since humans are its only natural host. A recent review of the disease sheds light on its clinical course and epidemiology.

  • Meningococcal disease takes its greatest toll in semi-arid regions of sub-Saharan Africa.
  • The infection is endemic in Brazil, causing occasional outbreaks, epidemics, and sporadic cases throughout the year, with winter episodes being most common.
  • Serogroups A and C were responsible for Brazilian epidemics in the 1970s.
  • Serogroups B, C, and Y are responsible for most cases in Europe, North and South America, and Australia.
  • Among the preventive measures that have helped thwart the spread of the infection are vaccination, chemoprophylaxis, and droplet precautions.

Citation:

Batista RS, Gomes AP, Dutra Gazineo JL, et al. Meningococcal disease, a clinical and epidemiological review. Asian Pac J Trop Med. 2017;10:1019-1029. doi:10.1016/j.apjtm.2017.10.004.